Freestone Grove Partners LP Purchases New Shares in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Freestone Grove Partners purchased 643,486 shares of Acadia Healthcare in the second quarter, valued at approximately $19.0 million and representing about 0.69% of the company.
• Acadia reported quarterly EPS of $0.38, exceeding estimates of $0.35, while revenue of $865.84 million also topped expectations. However, revenue declined 0.4% year over year and the company posted a negative net margin.
• Analyst sentiment is mixed: MarketBeat reports a consensus rating of “Hold” with an average price target of $29.85, compared with the stock’s recent price of $30.22.

Freestone Grove Partners LP purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 643,486 shares of the company's stock, valued at approximately $19,002,000. Freestone Grove Partners LP owned about 0.69% of Acadia Healthcare as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of ACHC. BlackRock Inc. bought a new stake in Acadia Healthcare during the 2nd quarter worth about $441,685,000. Goldman Sachs Group Inc. raised its position in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company's stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. bought a new position in Acadia Healthcare in the fourth quarter valued at approximately $47,960,000. Wellington Management Group LLP lifted its position in Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company's stock valued at $167,077,000 after acquiring an additional 2,350,760 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. bought a new stake in shares of Acadia Healthcare in the first quarter valued at about $43,017,000.

Acadia Healthcare Stock Down 1.2%

Acadia Healthcare stock opened at $30.22 on Friday. The company's 50-day moving average price is $30.39 and its two-hundred day moving average price is $26.04. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. The stock has a market cap of $2.81 billion, a P/E ratio of -2.43, a P/E/G ratio of 9.85 and a beta of 0.64. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm's revenue for the quarter was down .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Wall Street Analyst Weigh In

ACHC has been the topic of a number of research reports. Barclays boosted their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 30th. Raymond James Financial raised Acadia Healthcare from an "outperform" rating to a "strong-buy" rating and set a $39.00 price objective for the company in a research report on Monday, May 4th. Guggenheim boosted their target price on Acadia Healthcare from $38.00 to $39.00 and gave the stock a "buy" rating in a report on Thursday, July 30th. KeyCorp increased their price target on Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research note on Tuesday, July 14th. Finally, TD Cowen raised their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Hold" and an average price target of $29.85.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source